4.5 Article

Potent Antibacterial Composite Nonwovens Functionalized with Bioactive Peptides and Polymers

Journal

ADVANCED MATERIALS INTERFACES
Volume 9, Issue 33, Pages -

Publisher

WILEY
DOI: 10.1002/admi.202201061

Keywords

antimicrobial coating; bacitracin; controlled release; E; coli; polymyxin B; S; aureus; surface functionalization

Funding

  1. State of North Carolina
  2. National Science Foundation [DMR-1726294, ECCS1542015]

Ask authors/readers for more resources

This study presents strategies for producing potent antibacterial fabrics by functionalizing nonwoven fabrics with antimicrobial peptides and polymers. The results demonstrate the superior antibacterial activity of these fabrics and their good biocompatibility.
This study presents a set of strategies for producing potent antibacterial fabrics by functionalizing nonwoven fabrics (NWFs) with antimicrobial peptides and polymers (AMPs). The incorporation of AMPs is initially optimized on 2D substrates by evaluating conjugation on a poly(maleic anhydride) copolymer coating versus adsorption on polycationic/anionic films and microgels. The evaluation of the resulting surfaces against S. aureus and E. coli highlights the superior antibacterial activity of poly-ionic films loaded with daptomycin and polymyxin B as well as microgels featuring controlled release of bacitracin and polymyxin B. These formulations are translated onto spun-bond polypropylene and poly(ethylene terephthalate) NWFs. The poly-ionic coatings are either covalently anchored or physically adsorbed onto the surface of the fibers, while the microgels and antibacterial polymers are adsorbed and photo-crosslinked thereon using a ultraviolet (UV)-crosslinkable benzophenone-based polymer. Selected formulations loaded with bacitracin and polymyxin B afford a 10(5)-fold reduction of Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) in artificial sweat, respectively, on par with commercial antibacterial NWFs. The proposed antibacterial fabric, however, outperforms its commercial counterparts in terms of biocompatibility, showing virtually no adverse effect on human epidermal keratinocytes. Collectively, these results demonstrate affordable and scalable routes for developing antimicrobial NWFs that efficiently eliminate resilient pathogenic bacteria.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available